Analyst Price Target is $9.63
▲ +163.70% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Infinity Pharmaceuticals in the last 3 months. The average price target is $9.63, with a high forecast of $14.00 and a low forecast of $4.00. The average price target represents a 163.70% upside from the last price of $3.65.
Current Consensus is
The current consensus among 8 polled investment analysts is to buy stock in Infinity Pharmaceuticals. This Buy consensus rating has held steady for over two years.